The small molecule Mps1 inhibitors, commonly referred to as TTK inhibitors, CFI-402257, MPI-0479605 and NMS-P715 have been found to reduce tumor growth in hepatocellular carcinoma, lung cancer, ovarian cancer and melanoma xenograft models.106. The gene discussed is TTK; the disease is ovarian carcinoma.